THE INCREASE OF A NEW BIOTECH SECTOR DEDICATED TO LIFE EXTENSION

The Increase of a New Biotech Sector Dedicated to Life Extension

The Increase of a New Biotech Sector Dedicated to Life Extension

Blog Article

A nascent biotech sector dedicated to life extension has emerged in recent years, with a range of promising startups wanting to reverse the effects of maturing. These companies are developing medicines and therapies that combat senescence, reduce swelling, and stimulate cell regeneration.


AgeX Therapeutics


Detailed in the NYSE, AgeX Therapeutics develops medicines and therapies that target the underlying factors behind ageing and degenerative illnesses by restoring youthful regenerative capability. Brought by pioneer in tissue regeneration research Michael D West, the business is focused on several innovative cellular immortality options which includes cloning, telomerase treatment, splice-based treatments, and much more.


Calico / Alphabet / Calico Labs


As the health research and longevity technology subsidiary of Google's parent Alphabet, Calico is a leading developer of regenerative medications that fight aging. Its prospect drug applicant is really a recombinant type of GDF11 produced by scientists at Harvard University. Presently in preclinical trials, the compound has shown promise in regenerating muscle mass, heart, and mind tissues broken by age-related situations such as for example stroke and diabetes.


Longevity InTime & LessDeath


The Longevity InTime Community is a global community of health and life enthusiasts, dedicated to providing information, products and services that are helping people extend their life and improve their health. The community aims to help individuals live longer, healthier, and happier lives by providing real-time data on disease risk, early diagnosis of serious illnesses, and personalized recommendations for prevention.


Altos Labs / Amazon / Jeff Bezos & Yuri Milner


A team of scientists who've established eye-popping credentials in longevity analysis. Several domain professionals will work with Altos Labs, including Juan Carlos Izpisua Belmonte (a top practitioner and authority in regenerative medication), Steve Horvath (a geneticist and biostatistician who created a highly precise molecular biomarker for maturing), and Shinya Yamanaka (a Nobel Prize champion and a pioneer in cellular reprogramming).


Gero / Pfizer / Pfizer Pharmaceuticals


A preclinical-stage physics-allowed biotech company that generates therapeutics against chronic illnesses by slowing the deterioration of human being tissue themselves, Gero offers forged a partnership with pharma giant Pfizer. The two companies will use Gero's machine learning technology platform to identify possible targets for fibrotic illnesses and collaborate on preclinical growth and scientific trials.


Juvenescence / IPO of 2022 / Juvenescence LLC


The longevity-concentrated startup Juvenescence offers been able to raise over US$219.2 M in 5 rounds, including a Series A funding round led by Longevity Vision Fund, Grok Ventures, and IPGL. The company is situated in SAN FRANCISCO BAY AREA, California, and is targeted on regenerative medication, age administration, and improving metabolic efficiency through the use of artificial intelligence along with other technologies.


Elevian / IPO of 2022 / Elevian Inc


Elevian has developed a series of drug candidates that are capable of restoring a youthful regenerative capability in human beings and pets. The business's lead product is a recombinant version of GDF11 which has demonstrated the capability to regenerate heart, human brain, and muscle groups damaged by age-related problems.

Report this page